Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC

Yi‐Long Wu, Thomas John, Christian Grohé, Margarita Majem, Jonathan W. Goldman, Sang‐We Kim, Terufumi Kato, К. К. Лактионов, Hữu Vĩnh Vũ, Zhijie Wang, Shun Lü, Kye Young Lee, Charuwan Akewanlop, Chong‐Jen Yu, Filippo de Marinis, Laura Bonanno, Manuel Dómine, Frances A. Shepherd, Lingmin Zeng, Ajlan Atasoy, Roy S. Herbst, Masahiro Tsuboi